Prevention and management of bleeding complications after thrombolysis.
de Bono
D P
DP
Department of Cardiology, University of Leicester, Glenfield General Hospital, UK.
More
R S
RS
D007611:Aprotinin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017023:Coronary Angiography / Q000706:statistics & numerical data; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000628:therapy; D004347:Drug Interactions; D005340:Fibrinogen / Q000737:chemistry; D006470:Hemorrhage / Q000139:chemically induced / Q000453:epidemiology / Q000517:prevention & control*; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D015994:Incidence; D010949:Plasma; D012307:Risk Factors; D015912:Thrombolytic Therapy / Q000009:adverse effects* / Q000379:methods; D014148:Tranexamic Acid / Q000627:therapeutic use
D014148:Tranexamic Acid; D005340:Fibrinogen; D006493:Heparin; D007611:Aprotinin